8C5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.48 EUR -1.99% Market Closed

Market Cap: €169.8m

C	Coherus BioSciences Inc F:8C5	US
J	Jacobs Engineering Group Inc F:JEG	US
C	CF Industries Holdings Inc SWB:C4F	US
S	Singapore Airlines Ltd OTC:SINGF	SG
W	Wesfarmers Ltd XBER:WF3	AU
E	eHealth Inc F:M5V	US
	Golden Dawn Minerals Inc XTSX:GOM	CA
J	JSR Corp F:JYR	JP
S	Severn Trent PLC F:SVT1	UK
I	Impianti SpA F:F67	IT
	Agricultural Bank of China Ltd F:EK7	CN
S	Southstone Minerals Ltd OTC:FDGMF	CA
N	Nel ASA XHAM:D7G	NO
C	Chorus Ltd F:7CH	NZ
H	Havas NV OTC:HVBVF	FR
	Steel Partners Holdings LP NYSE:SPLP	US
A	Archer-Daniels-Midland Co SWB:ADM	US

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

58% > 67%

Negative Operating Margin

-410%

Negative 3Y Average Operating Margin

-170%

Declining Operating Margin

-130% > -410%

Exceptional Net Margin

398%

Sustainable 3Y Average Net Margin

19%

Net Margin is Increasing

-148% > 398%

Negative Free Cash Flow Margin

-328%

Negative 3Y Average Free Cash Flow Margin

-95%

Declining Free Cash Flow Margin

-140% > -328%

Negative ROE

-473%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-96% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.